[1]
Barnaś E, Ostańska E, Bartusik-Aebisher D, Dynarowicz K, Skręt-Magierło J, Aebisher D. Breast cancer tissue treated using photodynamic therapy. Acta Poloniae Pharmaceutica. 2022; 78, 6, 35-843. MEiN: 100; ImpF: 0,330.
[2]
Bartusik-Aebisher D, Ożóg Ł, Domka W, Aebisher D. Rose bengal and future directions in larynx tumor photodynamic therapy. Photochemistry and Photobiology, 2021. MEiN:70; ImpF: 3,421.
[3]
Międzybrodzka A, Bartusik-Aebisher D, Aebisher D, Cieślar G, Kawczyk-Krupka A. A review of preferential photosensitizers in brain cancer
photodiagnosis and photodynamic therapy. Acta Poloniae Pharmaceutica, 2021; 78 (4):457-465. MEiN: 100; ImpF: 0,330.
[4]
Machorowska-Pieniązek A, Morawiec T, Olek M, et al. Advantages
of using toothpaste containing propolis and plant oils for gingivitis prevention and oral cavity hygiene in cleft lip/palate patients. Biomedicine
& Pharmacotherapy, 2021; 142:111992. MEiN: 100; ImpF: 4,545.
[5]
Ostańska E, Aebisher D, Bartusik-Aebisher D. The potential of photodynamic therapy in current breast cancer treatment methodologies Biomedicine and Pharmacotherapy 2021: 137 MEiN: 100; IF: 4,545
[6]
Krupka M, Bożek A, Bartusik-Aebisher D, Cieślar G, Kawczyk-Krupka A. Photodynamic Therapy for the Treatment of Infected Leg Ulcers— A Pilot Study. Antibiotics. 2021. 10(5), 506. MEiN: 70; IF: 4, 639
[7]
Olek M, Machorowska-Pieniążk A, Stós W, et al. Photodynamic Therapy in Orthodontics: A Literature Review Pharmaceutics 2021 13, 720 MEiN: 100; ImpF: 6,321
[8]
Bartusik-Aebisher D, Ożóg Ł, Aebisher D. Alternative methods of photodynamic therapy and oxygen consumption measurements—A review.
Biomedicine & Pharmacotherapy 2021. v.134. MEiN: 100; IF: 4,545
[9]
Osuchowski M, Bartusik-Aebisher D, Osuchowski F, Aebisher D. Photodynamic therapy for prostate cancer– a narrative review. Photodiagnosis
and Photodynamic Therapy 2021. v. 70. MEiN: 70; IF: 2,894
[10]
Bartusik-Aebisher D, Chrzanowski G, Bober Z, Aebisher D. An analytical study of Trastuzumab-dendrimer-fluorine drug delivery system in
breast cancer therapy in vitro. Biomedicine & Pharmacotherapy 2021. v. 133. MEiN: 100; IF: 4,545
[11]
Bartusik-Aebisher D, Aebisher D, Czmil A, Mazur D. Evaluation of MR relaxation times following trastuzumab treatment of breast cancer cells
in a 3D bioreactor. Acta Poloniae Pharmaceutica. Drug Research. 2020. 77(1): 35-41. MEiN: 100; ImpF: 0,456
[12]
Bartusik-Aebisher D. Trastuzumab-dendrimer-fluorine drug delivery system Acta Poloniae Pharmaceutica Drug Research 2020 77( 2): 331-341
MEiN: 100; ImpF: 0,456
[13]
Bober Z, Pogoda K, Aebisher D, Tabarkiewicz J, Bartusik-Aebisher D. Contrast-enhanced magnetic resonance imaging of lung cell cultures
Acta Poloniae Pharmaceutica Drug Research 2020 77(2): 251-258 MEiN: 100; ImpF: 0,456
[14]
Krupka M, Bartusik-Aebisher D, Strzelczyk N, et al. The role of autofluorescence, photodynamic diagnosis and Photodynamic therapy in malignant tumors of the duodenum Photodiagnosis and Photodynamic Therapy 2020 v 32 MEiN: 70; ImpF: 2,894
[15]
Domka W, Ożóg Ł, Bartusik-Aebisher D, Aebisher D. Fluorescence diagnostics and photodynamic therapy in cancer Acta Poloniae Pharmaceutica
Drug Research 2020 77( 4), 517-540 MEiN: 100; ImpF: 0,456
[16]
Ożóg Ł, Domka W, Bartusik-Aebisher D, Aebisher D. Larynx tumor tissue response to photodynamic therapy with Rose Bengal Acta Poloniae
Pharmaceutica Drug Research 2020 77 (4): 581-586 MEiN: 100; ImpF: 0,456
[17]
Bober Z, Aebisher D, Pogoda K, Pucka M, Tabarkiewicz J, Bartusik-Aebisher D. Measurement of Lycopene Effectiveness on Lung and Kidney
Cancer Cells by Quantitative 1H Magnetic Resonance Imaging in vitro. Acta Poloniae Pharmaceutica. Drug Research 2020. 77 (4), 541-547.
MEiN: 100; ImpF: 0,456
[18]
Tabarkiewicz J, Bartusik-Aebisher D, Aebisher D. MRI as a potential tool for monitoring of therapeutic monoclonal antibody distribution in
cancer patients Acta Poloniae Pharmaceutica Drug Research 2020 77(3), 383-389 MEiN: 100; ImpF: 0,456
[19]
Bartusik-Aebisher D, Bober Z, Aebisher D. Selected applications of fluorinated MR contrast agents and fluorine containing drugs in medicine
Acta Poloniae Pharmaceutica Drug Research 2020 77(3), 403-410 MEiN: 100; ImpF: 0,456
[20]
Bartusik-Aebisher D, Aebisher D, Czmil A, Mazur D. Trastuzumab efficacy quantified by fluorine-19 magnetic resonance imaging Acta Poloniae
Pharmaceutica Drug Research 2020 77(3): 495-503 MEiN: 100; ImpF: 0,456
[21]
Chmiel Z, Żal M, Więch P, et al. Hypertension and selected indicators of
health assessment in a population of 19-year-old men subject to military qualifications. Medicine 2020. v. 99 (22). MEiN: 100; ImpF: 1,552
[22]
Domka W K. Ożóg. Ł.; Bartusik-Aebisher, D.; Aebisher, D. Fluorescence diagnostics and photodynamic therapy in cancer. Acta Poloniae Pharmaceutica-
Drug Resrarch, 2020, 77 (4 ), 517-540. MEiN: 100; ImpF: 0,456
[23]
Bartusik- Aebisher, D.; Aebisher. D.; Czmil, A.; Mazur, D. Evaluation of MR relaxation times following trastuzumab treatment of breast cancer cells
in a 3D bioreactor. Acta Poloniae Pharmaceutica. Drug Research 2020, 77: 35-41. MEiN: 100; ImpF: 0,456
[24]
Kawczyk‐Krupka A, Bartusik‐Aebisher D, Latos W, et al. Clinical trials and Basic Research in Photodynamic Diagnostics and Therapies from the Center for Laser Diagnostics and Therapy in Poland Photochemistry and Photobiology 2020 ISSN:1751-1097 MEiN: 100; ImpF: 2,721
[25]
Galiniak S, Biesiadecki M, Aebisher D, Rachel M. Nasal nitric oxide in upper airways in children with asthma and allergicrhinitis Advances in Medical Sciences 2020, 65 (1), 127-133 MEiN: 100; ImpF: 2,080
[26]
Bartusik-Aebisher D, Aebisher D, Podgórski R, Leksa N. The potential of fluorine 19F in targeted therapy. Acta Poloniae Pharmaceutica Drug
Research 2019. 76(6), 939-943. MEiN: 100; ImpF: 0,447
[27]
Bartusik- Aebisher, D.; Aebisher, D.; Courtney, R.; Sobczak, A.; Bober, Z.; Podgórski, R.; Kołodziejczyk, P.; Tutka, P. Applications of cytosine
extraction and detection in biological materials for clinical medicine. Acta Poloniae Pharmaceutica ñ Drug Research 2019. MEiN: 70; ImpF: 0,447
[28]
Bartusik-Aebisher D, Aebisher D, Podgórski R, Leksa N. The potential of fluorine 19F in targeted therapy. Acta Poloniae Pharmaceutica. Drug
Research 2019. 76(6): 939-943. MEiN: 70; ImpF: 0,447
[29]
Tutka P, Mróz K, Mróz T, et al. Effects of androsterone on the
protective action of various antiepileptic drugs against maximal electroshock- induced seizures in mice. Psychoneuroendocrinology 2019, 101: 27-
34. MEiN: 140; ImpF: 4,013
[30]
Galiniak S, Biesiadecki M, Czubat B. Bartusik- Aebisher, D. Przeciwglikacyjne właściwości kurkuminy. Postępy Higieny i Medycyny Doświadczalnej.
2019, 73: 182-188. MEiN: 40; ImpF: 0,878
[31]
Galiniak S, Aebisher D. Aebisher- Bartusik, D. Health benefits of resveratrol administration. Acta Biochimica Polonica 2019, 66(1): 13-2. MEiN:
40; ImpF: 1,420
[32]
Kaleta-Richter M, Kawczyk-Krupka A, Aebisher D, Bartusik-Aebisher D, Czuba Z, Cieślar G. The capability and potential of new forms of
personalized colon cancer treatment: Immunotherapy and Photodynamic Therapy. Photodiagnosis and Photodynamic Therapy 2019. 25: 253-258.
MEiN: 70; ImpF: 2,894
[33]
Tutka P, Wlaź A, Florek-Łuszczki M, Kołodziejczyk P, Bartusik-Aebisher D, Łuszczki J J. Arvanil, olvanil, AM 1172 and LY 2183240
(various cannabinoid CB1 receptor agonists) increase the threshold for maximal electroshock-induced seizures in mice. Pharmacological Reports,
2018, 70(1): 106-109. MEiN: 25; ImpF: 2,761
[34]
Aebisher D. Bartusik- Aebisher. D. Differential of Live and Dead Cells by Magnetic Resonance Imaging. Medicinal Chemistry Research 2017,
26(10): 2221-2224. MEiN: 20; ImpF: 1,607
[35]
Aebisher D. Bartusik- Aebisher, D. Tabarkiewicz J. Laser Flow Cytometry as a Tool for the Advancement of Clinical Medicine. Biomedicine and
Pharmacotherapy 2017. 85: 434-443. MEiN: 20; ImpF: 3,457
[36]
Bartusik D, Aebisher D. Multinuclear Magnetic Resonance Evaluation of Tumor Tissue Journal of Applied Biomedicine 2015 13(2), 69-78
MEiN: 20; ImpF:1,4
[37]
Bartusik D, Aebisher D, Tomanek B. A review of new approaches in Her-2 targeting and 1H MRI applications. Medicinal Chemistry Research
2015, 24(4): 1365-1368. MEiN: 20; ImpF: 1,37
[38]
Bartusik D, Aebisher D. 19F applications in drug development and imaging - a review. Biomedicine and Pharmacotherapy 2014, 68(6): 813-817.
MEiN: 20; ImpF: 2,68
[39]
Zhao Y, Liu Y, Xu Q, et al. Singlet Oxygen Generation on Porous Superhydrophobic Surfaces:
Effect of Gas Flow and Sensitizer Wetting on Trapping Efficiency. Journal of Physical Chemistry A 2014. 118. MEiN: 30; ImpF: 2,68
[40]
Aebisher D, Bartusik D, Liu Y, et al. Superhydrophobic Photosensitizers Mechanistic
Studies of 1O2 Generation in the Plastron and Solid/Liquid Droplet Interface Journal of American Chemical Society 2013, 135(50): 18990–18998
MEiN: 24; ImpF: 10,67
[41]
Bartusik D, Minnis M, Ghosh G, Greer A. Autocatalytic-Assisted Photorelease of a Sensitizer Drug Bound to a Silica Support Journal of Organic Chemistry 2013, 78(17): 8537-8544 MEiN: 35; ImpF: 4,564
[42]
Bartusik D, Tomanek B. Detection of 19F-Labeled Biopharmaceuticals in Cell Cultures with Magnetic Resonance. Advanced Drug Delivery Reviews
2013, 65(8): 1056-64. MEiN: 50; ImpF: 12,707
[43]
Bartusik D, Aebisher D, Ghogare A, et al. Fiberoptic (Photodynamic Therapy Type) Device with a
Photosensitizer and Singlet Oxygen Delivery Probe Tip for Ovarian Cancer Cell Killing. Photochemistry and Photobiology 2013,89: 936-941.
MEiN: 20; ImpF: 2,287
[44]
Bartusik D, Aebisher D, Lyons AM. Greer A62-66 Environmental Science and Technology 2012,46: 12098-12104 MEiN: 40; ImpF: 5,257
[45]
Kimani S, Ghosh G, Ghoghare A, et al. Synthesis and Characterization of Mono -, Di-, Tri-, Polyethylene
Glycol Chlorin e6 Conjugates for the Photokilling of Human Ovarian Cancer Cells. Journal of Organic Chemistry 2012, 77:10638-10647.
MEiN: 35; ImpF: 4,564
[46]
Bartusik D, Aebisher D, Ghafari B, Lyons AM, Greer A. Generating Singlet Oxygen Bubbles: A New Mechanism for Gas-Liquid Oxidations
in Water Langmuir 2012 28: 3053-3060 MEiN: 35; ImpF: 4,187
[47]
Bartusik D, Aebisher D, Ghosh G, Minnis M, Greer A. Fluorine End-Capped Optical Fibers for Photosensitizer Release and Singlet Oxygen
Production Journal of Organic Chemistry 2012 77: 4557-4565 (Featured Article) MEiN: 35; ImpF: 4,564
[48]
Bartusik D, Tomanek B. Detection of trastuzumab efficacy using 1H MRI ex vivo of breast cancer cells, Medicinal Chemistry Research 2012, 21:
2316-2319. MEiN: 20; ImpF:1,271
[49]
Lattová E, Bartusik D, Spicer V, Jellusova J, Perreault H, Tomanek B. Alterations in glycopeptides associated with herceptin treatment of
human breast carcinoma MCF-7 and T-lymphoblastoid cells. Molecular and Cellular Proteomics 2011. ImpF: 7,398
[50]
Bartusik D, Tomanek B, Fallone G. Monitoring of the 3-D Breast Carcinoma cell culture using proton magnetic resonance imaging, Medicinal
Chemistry Research 2010, 19(9). 1153-1161. MEiN: 20; ImpF: 1,058
[51]
Bartusik D, Tomanek B, Blicharska B. Fallone. G. Magnetic Resonance Assay of Haloperidol in Human Serum Albumine, Medicinal Chemistry
Research 2011. 20 : 62-66. MEiN: 20; ImpF: 1,271
[52]
Bartusik D, Tomanek B, Siluk D, Kaliszan R. 19F MRI of 3-D CEM cells to study the effects of tocopherols and tocotrienols, Journal of Pharmaceutical
and Biomedical Analysis 2010. 53(3), 599-602. MEiN: 35; ImpF: 2,733
[53]
Bartusik D, Tomanek B, Lattová E, Perreault H, Fallone G. Ex vivo assays of CEM cells cultured and treated in the three dimensional cultures,
Biomedicine and Pharmacotherapy 2010. 64(6), 390-395. MEiN: 20; ImpF: 2,208
[54]
Nugent A E, Reiter D A, Fishbein K W, McBurney D L, Murray T, Bartusik D. Ramaswamy, S.; Spencer, R. G. Horton, W. E. Jr. Characterization
of ex vivo-generated bovine and human cartilage by immunohistochemical, biochemical, and magnetic resonance imaging analyses, Tissue
Engineering Part A 2010, 16(7), 2183-2196. MEiN: 35; ImpF: 4,636
[55]
Lattova E, Tomanek B, Bartusik D, Perreault H. N-glycomic changes in Human Breast Carcinoma MCF-7 and T-Lymphoblastoid Cells after
Treatment with Herceptin and Herceptin/Lipoplex, Journal of Proteome Research 2010. 9 (3), 1533-1540. MEiN: 35; ImpF: 5,460
[56]
Bartusik D, Tomanek B. Application of 19F magnetic resonance to study the efficacy of fluorine labeled drugs in the three-dimensional cultured
breast cancer cells, Archives of Biochemistry and Biophysics 2010, 493: 234–241. MEiN: 25; ImpF: 3,022
[57]
Bartusik D, Tomanek B. Detection of fluorine labeled Herceptin using cellular 19F MRI ex vivo, Journal of Pharmaceutical and Biomedical Analysis
2010, 51: 894–900. MEiN: 35; ImpF: 2,733
[58]
Bartusik D, Tomanek B, Lattová E, Perreault H, Tuszynski J, Fallone G. Derivatives of thiocolchicine and its applications to CEM cells
treatment using 19F Magnetic Resonance ex vivo, Bioorganic Chemistry 2010. 38: 1–6. MEiN: 35; ImpF: 1,466
[59]
Bartusik D, Tomanek B, Lattová E, Perreault H, Fallone G. Combined Treatment of Human MCF-7 Breast Carcinoma with Antibody, Cationic
Lipid and Hyaluronic Acid Using ex vivo Assays, Journal of Pharmaceutical and Biomedical Analysis 2010, 51: 192–201. MEiN: 35; ImpF: 2,733
[60]
Bartusik D, Tomanek B, Lattová E, Perreault H, Tuszynski J, Fallone G. The efficacy of new Colchicine derivatives and viability of the TLymphoblastoid
cells in the three-dimensional culture using 19F MRI and HPLC-UV ex vivo, Bioorganic Chemistry 2009, 37: 193–201. MEiN: 15;
ImpF: 2,733
[61]
Bartusik D, Tomanek B, Siluk D, Kaliszan R, Fallone G. The application of 19F Magnetic Resonance ex vivo Imaging of 3D cultured breast
cancer cells to study the effect of δ-tocopherol, Analytical Biochemistry 2009, 387: 315-317. MEiN: 15; ImpF: 3,287
[62]
Bi X, Yang Xu, Bostrom M, et al. Fourier Transform Infrared Imaging
and MR Microscopy Studies Detect Compositional and Structural Changes in Cartilage in a Rabbit Model of Osteoarthritis, Analytical and Bioanalytical
Chemistry 2007. 387(5): 1601-1612. MEiN: 35; ImpF: 2,867.
[63]
Szczecinski P, Bartusik D. Derivatization of amino acids with Fluorine Containing Markers a Way for Their Determination by 19F NMR Spectroscopy,
Polish Journal of Chemistry 2004. 78: 1877-1883. MEiN: 15; ImpF: 0,640.
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Current Drug Therapy
Related Books
Nanotechnology in Drug Discovery
Drug Addiction Mechanisms in the Brain
Software and Programming Tools in Pharmaceutical Research
Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep
Biotechnology and Drug Development for Targeting Human Diseases
Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems
Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19
Advanced Pharmacy
Plant-derived Hepatoprotective Drugs
Article Metrics
8
3